| Date | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 1, 2026 | Hilger Christopher MDirector | Stock Award(Grant) at price 88.65 per share. | 402 | $35.64K |
| Oct 1, 2026 | Owens James JDirector | Stock Award(Grant) at price 88.65 per share. | 268 | $23.76K |
| Oct 1, 2026 | Smiley Jacinth CDirector | Stock Award(Grant) at price 88.65 per share. | 268 | $23.76K |
| Oct 1, 2026 | Rautio Trudy ADirector | Stock Award(Grant) at price 88.65 per share. | 336 | $29.79K |
| Sep 23, 2026 | Driesen Bart CPresident | Stock Award(Grant) at price 0.00 per share. | 4.5K | — |
| Sep 23, 2026 | Carpenter Tod EChief Executive Officer | Stock Award(Grant) at price 0.00 per share. | 38.1K | — |
| Sep 23, 2026 | Lewis Richard BrentPresident | Stock Award(Grant) at price 0.00 per share. | 6.3K | — |
| Sep 23, 2026 | Becker Amy C.Officer | Stock Award(Grant) at price 0.00 per share. | 6K | — |
| Sep 3, 2026 | Carpenter Tod EChief Executive Officer | Conversion of Exercise of derivative security at price 42.72 per share. | 32K | $1.37M |
| Sep 3, 2026 | Carpenter Tod EChief Executive Officer | Sale at price 91.10 per share. | 32K | $2.91M |
| Aug 30, 2026 | Carpenter Tod EChief Executive Officer | Conversion of Exercise of derivative security at price 42.72 per share. | 3K | $129.53K |
| Aug 30, 2026 | Carpenter Tod EChief Executive Officer | Sale at price 91.00 per share. | 3K | $275.91K |
| Aug 26, 2026 | Pogalz Bradley J.Chief Financial Officer | Conversion of Exercise of derivative security at price 42.72 per share. | 3K | $128.16K |
| Jul 1, 2026 | Hilger Christopher MDirector | Stock Award(Grant) at price 89.09 per share. | 400 | $35.64K |
| Jul 1, 2026 | Owens James JDirector | Stock Award(Grant) at price 89.09 per share. | 267 | $23.79K |
| Jul 1, 2026 | Smiley Jacinth CDirector | Stock Award(Grant) at price 89.09 per share. | 267 | $23.79K |
| Jul 1, 2026 | Rautio Trudy ADirector | Stock Award(Grant) at price 89.09 per share. | 334 | $29.76K |
| Apr 13, 2026 | Owens James JDirector | Conversion of Exercise of derivative security at price 42.26 - 48.96 per share. | 19.8K | $880.97K |
| Apr 13, 2026 | Owens James JDirector | Sale at price 88.82 - 89.21 per share. | 19.8K | $1.77M |
| Apr 1, 2026 | Hilger Christopher MDirector | Stock Award(Grant) at price 85.23 per share. | 418 | $35.63K |
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 15.0 | -9.0 | -8.5 | 3.9 | -7.1 | 9.6 | 5.0 | -3.6 | -4.2 | -0.5 | −2.3% | ||
| 2025 | 5.7 | -2.9 | -2.9 | -2.0 | 5.8 | -0.3 | 3.8 | 10.7 | 2.7 | 2.9 | 6.7 | -1.4 | +31.6% |
| 2024 | -1.2 | 10.9 | 4.3 | -3.3 | 2.0 | -2.9 | 4.6 | -2.8 | 1.3 | -0.7 | 6.7 | -13.7 | +3.1% |
| 2023 | 5.9 | 1.4 | 3.3 | -2.7 | -7.9 | 6.8 | 0.5 | 1.7 | -6.6 | -3.3 | 5.5 | 7.4 | +11.0% |
| 2022 | -6.1 | -2.5 | -4.3 | -5.6 | 6.6 | -7.9 | 13.0 | -5.6 | -4.6 | 17.2 | 6.0 | -3.4 | −0.7% |
| 2021 | 6.4 | -0.9 | -1.3 | 8.1 | -2.1 | 3.1 | 4.2 | 2.4 | -15.3 | 4.5 | -6.0 | 5.0 | +6.0% |
| 2020 | -10.0 | -13.1 | -14.3 | 13.5 | 8.3 | -2.0 | 3.9 | 4.2 | -7.8 | 2.3 | 12.1 | 5.0 | −3.0% |
| 2019 | 9.0 | 9.1 | -3.0 | 7.0 | -11.4 | 7.2 | -1.8 | -3.2 | 7.7 | 1.3 | 6.3 | 2.7 | +32.8% |
| 2018 | 3.5 | -6.3 | -5.1 | -1.8 | 6.6 | -4.4 | 5.7 | 6.1 | 15.1 | -12.0 | 9.3 | -22.6 | −11.4% |
| 2017 | 0.4 | 1.7 | 6.0 | 1.7 | 3.6 | -5.0 | 4.3 | -0.5 | -2.8 | 2.8 | 5.7 | -1.9 | +16.3% |
| 2016 | -1.7 | 0.2 | 13.0 | 2.4 | 2.5 | 2.5 | 5.2 | 3.9 | -0.6 | -2.2 | 11.1 | 3.7 | +46.8% |
| 2015 | -5.4 | 1.3 | 1.8 | -0.9 | -4.6 | 0.4 | -6.1 | -6.8 | -10.3 | 7.5 | 4.0 | -8.7 | −25.8% |
| 2014 | -5.1 | 3.8 | -1.0 | -0.7 | -3.2 | 3.9 | -8.3 | 7.9 | -2.9 | 2.3 | -6.2 | -0.9 | −11.1% |
| 2013 | 14.5 | -4.2 | 0.4 | 0.5 | 3.1 | -4.9 | 1.7 | -2.8 | 8.2 | 3.9 | 5.4 | 4.1 | +32.3% |
| 2012 | 6.2 | 1.6 | -2.7 | -3.0 | 3.2 | -6.7 | 2.3 | 3.4 | -1.6 | -7.0 | 4.1 | -2.2 | −3.5% |
| 2011 | 0.5 | -3.9 | 8.9 | -0.1 | -2.5 | 1.6 | -8.7 | 6.5 | -7.1 | 16.9 | 6.7 | -0.4 | +16.8% |
| 2010 | -10.1 | 7.9 | 9.4 | 2.6 | -6.8 | -1.2 | 11.3 | -11.7 | 12.5 | 3.4 | 11.4 | 7.3 | +37.0% |
| 2009 | -7.5 | -21.6 | 10.0 | 22.9 | 2.1 | 2.8 | 9.7 | -1.2 | -7.8 | 3.0 | 19.1 | 0.1 | +26.4% |
| 2008 | -9.7 | 0.7 | -4.5 | 8.1 | 18.2 | -13.3 | 1.1 | -2.7 | -4.6 | -16.1 | -2.6 | -1.7 | −27.4% |
| 2007 | 1.5 | 1.8 | 0.7 | -0.5 | 1.7 | -2.7 | 2.4 | 4.9 | 9.4 | 2.6 | 9.1 | -0.9 | +33.6% |
| Investor | Value | Of portfolio | Shares | Change | Quarter |
|---|---|---|---|---|---|
| Bridgewater Associates · Ray Dalio | $1.4M | 0.01% | 15.09K | New | Q2 2026 |
From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors
Donaldson Company, Inc. manufactures and sells filtration systems and replacement parts worldwide. The company operates through Mobile Solutions, Industrial Solutions, and Life Sciences segments. The Mobile Solutions segment provides replacement filters for air and liquid filtration applications, such as air filtration systems, fuel, lube and hydraulic systems, emissions systems and sensors, indicators, and monitoring systems. This segment sells its products to original equipment manufacturers (OEMs) in the construction, mining, agriculture, and transportation markets; and to independent distributors, and OEM dealer networks. The Industrial Solutions segment offers dust, fume, and mist collectors; compressed air and industrial gasses purification systems; air inlet systems and filtration for power generation; ancillary components; replacement parts; performance monitoring and service; and hydraulic and lubricated rotating equipment applications, as well as gas and liquid filtration for industrial processes and connected services. It also sells aerospace and defense products comprising of air, fuel, lubrication and hydraulic filtration for fixed-wing and rotorcraft aerospace platforms, missile systems, and ground defense vehicles and naval platforms. This segment sells its products to various distributors, OEMs, and direct-to-consumer. The Life Sciences segment provides micro-environment gas and liquid filtration for food, beverage, and industrial processes; bioprocessing equipment that includes bioreactors and fermenters; and bioprocessing consumables, such as chromatography devices, reagents and filters, and polytetrafluoroethylene membrane-based products, as well as specialized air and gas filtration systems for applications, including hard disk drives, semi-conductor manufacturing and sensors, battery systems, and powertrain components to OEMs and various end-users. The company was founded in 1915 and is headquartered in Bloomington, Minnesota.
Buy / hold / sell counts
No member of Congress has disclosed a DCI trade since 2025.
From House and Senate STOCK Act reports. Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades